Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study
Purpose: The purpose was to evaluate the activity and toxicity of split-dose paclitaxel or docetaxel in combination with gemcitabine in patients with metastatic breast cancer (MBC) who had previously received anthracyclines. Patients and methods: A total of 210 patients were randomly assigned to one...
Saved in:
Main Authors: | Kei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, Santai Song, Reena Nair, Corazon A. Ngelangel, Anita Bustam, William H.H. Reece, Manfred Lehnert |
---|---|
Other Authors: | National Cancer Centre, Singapore |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/23004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
by: Chalyut Charoentum, et al.
Published: (2018) -
Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
by: Chan, D., et al.
Published: (2014) -
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
by: Ashrafizadeh, Milad, et al.
Published: (2022) -
Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer
by: Chitapanarux,I., et al.
Published: (2015) -
Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer
by: Chitapanarux I., et al.
Published: (2014)